Recently, in a meta-analysis of randomized clinical trials, Lotito et al. had suggested that obesity is often associated with vitamin D deficiency as well as secondary hyperparathyroidism, and vitamin D supplementation typically leads to the reductions in PTH levels [28]. The gene discussed is PTH; the disease is secondary hyperparathyroidism.